Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2026-03-01 @ 12:20 AM
Study NCT ID:
NCT02875132
Status:
COMPLETED
Last Update Posted:
2025-04-18
First Post:
2016-08-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma
Sponsor:
Chinese University of Hong Kong
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MEL001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None